Sun closes in on Taro as tender offer extended
This article was originally published in Scrip
Executive Summary
Sun Pharmaceutical Industries has closed an initial tender offer to purchase all outstanding ordinary shares of Taro Pharmaceutical Industries, moving it a step closer to acquiring its long-eyed target.